Showing results (71-80 of 229) with videos related to
Sort By:
Pageof 23
Leukemia & Lymphoma|September 20, 2019
<i>De novo</i> CD5+ diffuse large B-cell lymphoma, NOS: clinical characteristics and outcomes in rituximab eraBei Hu, Loretta J Nastoupil, Sanam Loghavi, et al.Journal of the National Cancer Institute|January 2, 2017
Recommendations for Clinical Trial Development in Follicular LymphomaKami Maddocks, Paul M Barr, Bruce D Cheson, et al.British Journal of Haematology|January 7, 2014
The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin lymphomaYasuhiro Oki, Hubert Chuang, Beth Chasen, et al.International Journal of Radiation Oncology, Biology, Physics|February 16, 2019
Outcomes After Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa-Associated Lymphoid Tissue (MALT) LymphomaChelsea C Pinnix, Jillian R Gunther, Sarah A Milgrom, et al.Carcinogenesis|March 16, 2002
CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinomaAtsuko Shibata, Julie Parsonnet, Teri A Longacre, et al.Haematologica|October 16, 2016
Inhibition of demethylase KDM6B sensitizes diffuse large B-cell lymphoma to chemotherapeutic drugsRohit Mathur, Lalit Sehgal, Ondrej Havranek, et al.The American Journal of Surgical Pathology|August 18, 2017
Primary Bone Lymphoma Exhibits a Favorable Prognosis and Distinct Gene Expression Signatures Resembling Diffuse Large B-Cell Lymphoma Derived From Centrocytes in the Germinal CenterXin Li, Zijun Y Xu-Monette, Shuhua Yi, et al.Frontiers in Immunology|October 16, 2025
Mutation of conserved MHC class I cytoplasmic tyrosine affects CD8+ T cell priming, effector function, and memory responseYimo Sun, Yitao Tang, Priscilla Ortiz, et al.Blood|September 28, 2019
Ublituximab and umbralisib in relapsed/refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemiaMatthew Lunning, Julie Vose, Loretta Nastoupil, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2013
Phase I study of panobinostat plus everolimus in patients with relapsed or refractory lymphomaYasuhiro Oki, Daniela Buglio, Michelle Fanale, et al.Pageof 23